India · Delayed Price · Currency is INR Poly Medicure Statistics
Total Valuation
Poly Medicure has a market cap or net worth of INR 143.91 billion. The enterprise value is 139.61 billion.
| Market Cap | 143.91B |
| Enterprise Value | 139.61B |
Important Dates
The last earnings date was Monday, May 25, 2026.
| Earnings Date | May 25, 2026 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
| Current Share Class | 101.36M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.23% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 39.71% |
| Owned by Institutions (%) | 20.88% |
| Float | 33.57M |
Valuation Ratios
The trailing PE ratio is 44.67 and the forward PE ratio is 37.03.
| PE Ratio | 44.67 |
| Forward PE | 37.03 |
| PS Ratio | 7.67 |
| PB Ratio | 4.57 |
| P/TBV Ratio | 5.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 58.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.16, with an EV/FCF ratio of -225.11.
| EV / Earnings | 43.34 |
| EV / Sales | 7.44 |
| EV / EBITDA | 31.16 |
| EV / EBIT | 41.99 |
| EV / FCF | -225.11 |
Financial Position
The company has a current ratio of 3.37, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.37 |
| Quick Ratio | 2.36 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.80 |
| Debt / FCF | -5.70 |
| Interest Coverage | 17.87 |
Financial Efficiency
Return on equity (ROE) is 10.84% and return on invested capital (ROIC) is 10.32%.
| Return on Equity (ROE) | 10.84% |
| Return on Assets (ROA) | 5.74% |
| Return on Invested Capital (ROIC) | 10.32% |
| Return on Capital Employed (ROCE) | 9.78% |
| Weighted Average Cost of Capital (WACC) | 4.91% |
| Revenue Per Employee | 6.08M |
| Profits Per Employee | 1.05M |
| Employee Count | 3,082 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.66 |
Taxes
In the past 12 months, Poly Medicure has paid 1.07 billion in taxes.
| Income Tax | 1.07B |
| Effective Tax Rate | 24.97% |
Stock Price Statistics
The stock price has decreased by -38.00% in the last 52 weeks. The beta is 0.13, so Poly Medicure's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -38.00% |
| 50-Day Moving Average | 1,451.38 |
| 200-Day Moving Average | 1,680.35 |
| Relative Strength Index (RSI) | 43.78 |
| Average Volume (20 Days) | 205,804 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Poly Medicure had revenue of INR 18.75 billion and earned 3.22 billion in profits. Earnings per share was 31.75.
| Revenue | 18.75B |
| Gross Profit | 12.78B |
| Operating Income | 3.27B |
| Pretax Income | 4.27B |
| Net Income | 3.22B |
| EBITDA | 4.42B |
| EBIT | 3.27B |
| Earnings Per Share (EPS) | 31.75 |
Balance Sheet
The company has 8.27 billion in cash and 3.54 billion in debt, with a net cash position of 4.73 billion.
| Cash & Cash Equivalents | 8.27B |
| Total Debt | 3.54B |
| Net Cash | 4.73B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 31.49B |
| Book Value Per Share | 306.44 |
| Working Capital | 13.66B |
Cash Flow
In the last 12 months, operating cash flow was 2.46 billion and capital expenditures -3.08 billion, giving a free cash flow of -620.17 million.
| Operating Cash Flow | 2.46B |
| Capital Expenditures | -3.08B |
| Depreciation & Amortization | 1.16B |
| Net Borrowing | 712.38M |
| Free Cash Flow | -620.17M |
| FCF Per Share | n/a |
Margins
Gross margin is 68.17%, with operating and profit margins of 17.43% and 17.18%.
| Gross Margin | 68.17% |
| Operating Margin | 17.43% |
| Pretax Margin | 22.80% |
| Profit Margin | 17.18% |
| EBITDA Margin | 23.59% |
| EBIT Margin | 17.43% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 0.27%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 0.27% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 11.00% |
| Buyback Yield | -2.23% |
| Shareholder Yield | -1.97% |
| Earnings Yield | 2.24% |
| FCF Yield | -0.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Poly Medicure is 1,578.83, which is 14.04% higher than the current price. The consensus rating is "Hold".
| Price Target | 1,578.83 |
| Price Target Difference | 14.04% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 17.86% |
| EPS Growth Forecast (3Y) | 24.12% |
Stock Splits
The last stock split was on March 24, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Mar 24, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |